This CDC National Center for Immunization and Respiratory Diseases (NCIRD) grant is for collaborative research on influenza and other respiratory pathogens in South Africa. NCIRD seeks a cooperative agreement with South Africa’s National Institute for Communicable Diseases (NICD) to conduct studies. Research areas include surveillance (epidemiology, disease burden, transmission, lab methods), preventive tools (vaccines, antivirals), and strategies to increase intervention coverage. The goal is to generate data informing the prioritization of public health interventions for high-risk populations in South Africa, the region, and globally.
Opportunity ID: 351637
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-IP-24-017 |
| Funding Opportunity Title: | Collaborative research on influenza and other respiratory pathogens in South Africa |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.083 — Prevention of Disease, Disability, and Death through Immunization and Control of Respiratory and Related Diseases |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Dec 22, 2023 |
| Last Updated Date: | Dec 22, 2023 |
| Original Closing Date for Applications: | Mar 07, 2024 Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date. |
| Current Closing Date for Applications: | Mar 07, 2024 Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date. |
| Archive Date: | Apr 06, 2024 |
| Estimated Total Program Funding: | $15,000,000 |
| Award Ceiling: | $2,500,000 |
| Award Floor: | $1,000,000 |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | National Institute for Communicable Diseases, Republic of South Africa |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention – ERA |
| Description: | The purpose of this notice of funding opportunity is to conduct research studies on influenza and other respiratory pathogens of public health import in South Africa. The National Center for Immunization and Respiratory Diseases (NCIRD) in CDC is seeking to initiate a cooperative agreement with the National Institute for Communicable Diseases (NICD), Republic of South Africa, to conduct research on surveillance (inclusive of the epidemiology, disease burden, transmission, and laboratory methods), preventive tools and strategies (e.g., vaccines, antivirals), and strategies for increasing coverage of morbidity and mortality mitigating interventions. Data will be used to inform prioritization of public health interventions in high-risk populations in South Africa, the region, and globally. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Dr. Jamal Bankhead
JBankhead@cdc.gov Email:JBankhead@cdc.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 351637 Full Announcement-Full Announcement -> Foa_Content_of_RFA-IP-24-017 final.pdf
Packages
| Agency Contact Information: | Dr. Jamal Bankhead JBankhead@cdc.gov Email: JBankhead@cdc.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 93.083 | RFA-IP-24-017 | Collaborative research on influenza and other respiratory pathogens in South Africa | PKG00284290 | Dec 22, 2023 | Mar 07, 2024 | View |
Package 1
Mandatory forms
351637 RR_SF424_5_0-5.0.pdf
351637 PHS398_CoverPageSupplement_5_0-5.0.pdf
351637 RR_OtherProjectInfo_1_4-1.4.pdf
351637 PHS398_ResearchPlan_5_0-5.0.pdf
351637 PerformanceSite_4_0-4.0.pdf
351637 RR_KeyPersonExpanded_4_0-4.0.pdf
351637 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
351637 RR_Budget_3_0-3.0.pdf
Optional forms
351637 RR_SubawardBudget30_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
